CAPLIN POINT LABORATORIES LTD. - 524742 - Corporate Action-Board approves Dividend
Declaration of Interim Dividend of Rs.2/- (100%) for the Financial Year 2021-2212-05-2022
12-05-2022
CAPLIN POINT LABORATORIES LTD. - 524742 - Outcome Of Board Meeting -
1. Declared an Interim Dividend of Rs. 2/- (100 %) per equity share of Rs.2 each for the financial year ended March 31, 2022. 2. Fixed 24th May 2022 as Record Date for determining the eligibility of the Shareholders for the purpose of Interim Dividend. 3. Approved the Audited standalone and consolidated financial results (Annexure-1) of the Company as per Indian Accounting Standards for the year ending March 31, 2022 along with Auditors Report (Annexure - 2). We also enclose a Press Release issued by the Company (Annexure 3) and an investor presentation in this regard (Annexure 4).12-05-2022
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Compliance under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201509-05-2022
CAPLIN POINT LABORATORIES LTD. - 524742 - Board to consider FY22 results & Interim Dividend on May 12, 2022
Caplin Point Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 12, 2022, inter alia, to consider and approve:1. the annual audited financial results of the Company for the year ended March 31, 2022 (both standalone & consolidated) and2. declaration of Interim Dividend, if any, for the FY 2021-22 and fixation of record date for determining the eligibility of shareholders.As informed earlier vide letter dated March 28, 2022, the trading window for dealing in the Company's scrips by the Directors and Designated Employees of the Company will remain closed from April 01, 2022 to May 14, 2022 (both days inclusive), in terms of the Company's Code of Conduct to regulate, monitor and report trading by insiders, read with SEBI (Prohibition of Insider Trading) Regulations, 2015.05-05-2022
CAPLIN POINT LABORATORIES LTD. - 524742 - Board Meeting Intimation for Board Meeting Intimation
CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2022 ,inter alia, to consider and approve Board meeting intimation to consider and approve, inter-alia: i) the annual audited financial results of the Company for the year ended 31st March 2022 (both standalone & consolidated) and ii) declaration of Interim Dividend, if any, for the FY 2021-22 and fixation of record date for determining the eligibility of shareholders.05-05-2022
CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 201529-04-2022
CAPLIN POINT LABORATORIES LTD. - 524742 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayCAPLIN POINT LABORATORIES LTD. 2CINL24231TN1990PLC019053 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY Nil 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Dinesh R G Designation: Company Secretary EmailId: rgdinesh@caplinpoint.net Name of the Chief Financial Officer: D Muralidharan Designation: Chief Financial Officer EmailId: dmuralidharan@caplinpoint.net Date: 29/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.29-04-2022
CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 201512-04-2022
CAPLIN POINT LABORATORIES LTD. - 524742 - Certificate Pursuant To Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Certificate pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 201511-04-2022